Australia markets close in 5 hours 53 minutes

Kiromic BioPharma, Inc. (5JU0.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
4.09950.0000 (0.00%)
At close: 03:56PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
10,572
9,625
13,920
11,368
5,053
-
Selling general and administrative
9,703
10,314
17,194
13,938
14,144
-
Total operating expenses
20,275
19,939
31,114
25,306
19,197
-
Operating income or loss
-20,275
-19,939
-31,114
-25,306
-19,197
-
Interest expense
2,479
1,852
166.5
12.2
3.3
-
Total other income/expenses net
-
842.2
-3,450
-270.8
-
-
Income before tax
-21,797
-20,949
-34,731
-25,589
-19,200
-
Income tax expense
-
-
-
-
-
0
Income from continuing operations
-21,797
-20,949
-34,731
-25,589
-19,200
-
Net income
-21,797
-20,949
-34,731
-25,589
-19,200
-
Net income available to common shareholders
-25,237
-23,499
-35,076
-25,811
-19,913
-
Basic EPS
-
-
-64.41
-67.81
-132.60
-30.76
Diluted EPS
-
-
-64.41
-67.81
-132.60
-30.76
Basic average shares
-
-
544.529
380.607
150.195
129.323
Diluted average shares
-
-
544.529
380.607
150.195
129.323